ASX 200 Ends Flat At 8,820 After Volatile Day, Even As Neuren Pharmaceuticals Stuns With 36% Surge
The ASX 200 closed nearly unchanged, buoyed by a biotech surge and easing geopolitical tensions, while investors await Chinese manufacturing data and Reserve Bank policy updates.






































